Published in J Virol on March 07, 2007
Formation of the tRNALys packaging complex in HIV-1. FEBS Lett (2010) 1.11
Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1. J Virol (2011) 0.97
A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release. J Virol (2009) 0.85
The y271 and i274 amino acids in reverse transcriptase of human immunodeficiency virus-1 are critical to protein stability. PLoS One (2009) 0.84
Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production. PLoS One (2012) 0.80
HIV Genome-Wide Protein Associations: a Review of 30 Years of Research. Microbiol Mol Biol Rev (2016) 0.75
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1989) 12.54
Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci U S A (1988) 10.77
Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature (1988) 10.69
Form, function, and use of retroviral gag proteins. AIDS (1991) 9.24
Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci U S A (1990) 8.23
HIV-1 gag proteins: diverse functions in the virus life cycle. Virology (1998) 7.32
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A (1993) 6.44
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J Virol (1997) 5.73
Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J Virol (1989) 5.15
Construction and use of a human immunodeficiency virus vector for analysis of virus infectivity. J Virol (1990) 5.01
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci U S A (1997) 4.59
Viral late domains. J Virol (2002) 4.51
Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J Virol (2003) 4.47
Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. J Virol (2000) 3.77
Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis. J Virol (1994) 3.48
Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science (1996) 3.25
Assembly properties of the human immunodeficiency virus type 1 CA protein. J Virol (2004) 3.09
A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly. J Virol (1998) 3.06
Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles. J Virol (1993) 2.69
Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J Virol (1998) 2.62
Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J Virol (1995) 2.56
The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J Virol (1992) 2.51
The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles. J Virol (1992) 2.17
Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol (1999) 2.16
Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly. AIDS Res Hum Retroviruses (1990) 2.15
Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles. J Virol (2000) 2.00
Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag. J Virol (2002) 1.96
The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly. J Virol (1998) 1.91
Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J Virol (1995) 1.73
Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins. J Virol (2004) 1.58
Role of HIV-1 Gag domains in viral assembly. Biochim Biophys Acta (2003) 1.53
Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro. J Virol (1997) 1.37
Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release. J Virol (1998) 1.32
Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain. J Virol (2005) 1.24
Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1. J Virol (2003) 1.23
The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release. J Virol (2004) 1.18
HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other. FEBS Lett (2001) 1.17
Analysis of mutations and suppressors affecting interactions between the subunits of the HIV type 1 reverse transcriptase. Proc Natl Acad Sci U S A (2000) 1.06
HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins. AIDS Rev (2005) 1.04
Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication. Virology (1997) 1.00
Selected amino acid substitutions in the C-terminal region of human immunodeficiency virus type 1 capsid protein affect virus assembly and release. J Gen Virol (2004) 0.98
Association of murine leukemia virus pol with virions, independent of Gag-Pol expression. J Virol (1999) 0.96
A role for the aspartyl protease from the human immunodeficiency virus type 1 (HIV-1) in the orchestration of virus assembly. Ann N Y Acad Sci (1990) 0.90
Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-pol. J Virol (2004) 0.88
A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag-Pol. Virology (2006) 0.87
Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain. Virology (2004) 0.85
The human immunodeficiency virus type 1 carboxyl-terminal third of capsid sequence in Gag-Pol is essential but not sufficient for efficient incorporation of Pr160(gag-pol) into virus particles. J Biomed Sci (2004) 0.77
An expanded palette of genetically encoded Ca²⁺ indicators. Science (2011) 5.05
AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell (2005) 2.68
Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS Pathog (2010) 1.85
Impaired phagocytosis of capsular serotypes K1 or K2 Klebsiella pneumoniae in type 2 diabetes mellitus patients with poor glycemic control. J Clin Endocrinol Metab (2006) 1.71
High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess. Microbes Infect (2004) 1.59
Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts. J Virol (2003) 1.55
Improved orange and red Ca²± indicators and photophysical considerations for optogenetic applications. ACS Chem Neurosci (2013) 1.26
Rab11-FIP1C and Rab14 direct plasma membrane sorting and particle incorporation of the HIV-1 envelope glycoprotein complex. PLoS Pathog (2013) 1.11
Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis. J Cell Physiol (2012) 1.07
Mutations in capsid major homology region affect assembly and membrane affinity of HIV-1 Gag. J Mol Biol (2007) 1.05
Association of Japanese encephalitis virus NS3 protein with microtubules and tumour susceptibility gene 101 (TSG101) protein. J Gen Virol (2003) 1.00
Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages. Cell Host Microbe (2012) 1.00
Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. J Acquir Immune Defic Syndr (2010) 1.00
Human immunodeficiency virus type-1 gag and host vesicular trafficking pathways. Curr Top Microbiol Immunol (2009) 0.97
The intracellular virus-containing compartments in primary human macrophages are largely inaccessible to antibodies and small molecules. PLoS One (2012) 0.96
Molecular epidemiology of HIV-1 infection and full-length genomic analysis of circulating recombinant form 07_BC strains from injection drug users in Taiwan. J Infect Dis (2007) 0.94
HIV-1 matrix protein repositioning in nucleocapsid region fails to confer virus-like particle assembly. Virology (2008) 0.93
Mutations in the alpha-helix directly C-terminal to the major homology region of human immunodeficiency virus type 1 capsid protein disrupt Gag multimerization and markedly impair virus particle production. J Biomed Sci (2006) 0.90
The tetherin/BST-2 coiled-coil ectodomain mediates plasma membrane microdomain localization and restriction of particle release. J Virol (2011) 0.90
Synergism of Rana catesbeiana ribonuclease and IFN-gamma triggers distinct death machineries in different human cancer cells. FEBS Lett (2005) 0.89
A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase. Anal Biochem (2010) 0.89
Characterization of a myristoylated, monomeric HIV Gag protein. Virology (2009) 0.89
Histologic examination of pedicled buccal fat pad graft in oral submucous fibrosis. J Oral Maxillofac Surg (2002) 0.89
Mutations at human immunodeficiency virus type 1 reverse transcriptase tryptophan repeat motif attenuate the inhibitory effect of efavirenz on virus production. Virology (2008) 0.88
A domain directly C-terminal to the major homology region of human immunodeficiency type 1 capsid protein plays a crucial role in directing both virus assembly and incorporation of Gag-Pol. Virology (2006) 0.87
Demonstration of an olfactory bulb-brain translocation pathway for ZnO nanoparticles in rodent cells in vitro and in vivo. J Mol Neurosci (2012) 0.86
Oligomerization of the carboxyl terminal domain of the human coronavirus 229E nucleocapsid protein. FEBS Lett (2012) 0.86
A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release. J Virol (2009) 0.85
Self-assembly of severe acute respiratory syndrome coronavirus membrane protein. J Biol Chem (2010) 0.85
Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain. Virology (2004) 0.85
Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing. J Gen Virol (2006) 0.84
Effect of point mutations in the N terminus of the lentivirus lytic peptide-1 sequence of human immunodeficiency virus type 1 transmembrane protein gp41 on Env stability. J Biol Chem (2002) 0.84
Effects of gag mutations on human immunodeficiency virus type 1 particle assembly, processing, and cyclophilin A incorporation. J Med Virol (2002) 0.82
PKC and MEK pathways inhibit caspase-9/-3-mediated cytotoxicity in differentiated cells. FEBS Lett (2008) 0.82
The cytotoxic protein can induce autophagocytosis in addition to apoptosis in MCF-7 human breast cancer cells. In Vivo (2012) 0.81
Rana catesbeiana ribonuclease inhibits Japanese encephalitis virus (JEV) replication and enhances apoptosis of JEV-infected BHK-21 cells. Antiviral Res (2011) 0.81
Severe acute respiratory syndrome coronavirus nucleocapsid protein confers ability to efficiently produce virus-like particles when substituted for the human immunodeficiency virus nucleocapsid domain. J Biomed Sci (2008) 0.81
Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis. J Rheumatol (2008) 0.81
Restriction of Retroviral Replication by Tetherin/BST-2. Mol Biol Int (2012) 0.80
Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production. PLoS One (2012) 0.80
Treatment of focal cerebral ischemia with liposomal nerve growth factor. Drug Deliv (2005) 0.80
Electromechanical properties of Purkinje fiber strands isolated from human ventricular endocardium. J Heart Lung Transplant (2004) 0.80
Mutations in the HIV-1 reverse transcriptase tryptophan repeat motif affect virion maturation and Gag-Pol packaging. Virology (2011) 0.79
GSTP1 genetic polymorphism is associated with a higher risk of DNA damage in pesticide-exposed fruit growers. Cancer Epidemiol Biomarkers Prev (2006) 0.79
APOBEC3G cytidine deaminase association with coronavirus nucleocapsid protein. Virology (2009) 0.79
Transforming growth factor-beta2 inhibition of corneal endothelial proliferation mediated by prostaglandin. Curr Eye Res (2003) 0.78
RC-RNase-induced cell death in estrogen receptor positive breast tumors through down-regulation of Bcl-2 and estrogen receptor. Oncol Rep (2010) 0.78
Optical measurement of the deformation of giant lipid vesicles driven by a micropipet electrode. Langmuir (2005) 0.77
Gene transfer mediated by sphingosine/ dioleoylphosphatidylethanolamine liposomes in the presence of poloxamer 188. Drug Deliv (2006) 0.77
Identifying SARS-CoV membrane protein amino acid residues linked to virus-like particle assembly. PLoS One (2013) 0.77
The human immunodeficiency virus type 1 carboxyl-terminal third of capsid sequence in Gag-Pol is essential but not sufficient for efficient incorporation of Pr160(gag-pol) into virus particles. J Biomed Sci (2004) 0.77
Orai1-STIM1 formed store-operated Ca2+ channels (SOCs) as the molecular components needed for Pb2+ entry in living cells. Toxicol Appl Pharmacol (2007) 0.76
Effects of mutations in an HIV-1 gag gene containing a 107-codon tandem repeat in the matrix region on assembly and processing of the protein product. J Med Virol (2004) 0.76
Detection of the interaction between SNAP25 and rabphilin in neuroendocrine PC12 cells using the FLIM/FRET technique. Microsc Res Tech (2008) 0.76
SARS-CoV envelope protein palmitoylation or nucleocapid association is not required for promoting virus-like particle production. J Biomed Sci (2014) 0.75
Linear-long incisions with a small optical zone for the correction of astigmatism in older patients. Ophthalmology (2004) 0.75
Efficient in silico assay of inhibitors of hepatitis C Virus RNA-dependent RNA polymerase by structure-based virtual screening and in vitro evaluation. Assay Drug Dev Technol (2011) 0.75
Management of anembryonic pregnancy loss: an observational study. J Chin Med Assoc (2010) 0.75
Characterization of a highly attenuated Salmonella enterica serovar Typhimurium mutant strain. J Microbiol Immunol Infect (2002) 0.75
Corneal injury by anti-misting agent in swim goggles: a case report. Cornea (2006) 0.75
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-alpha blocker therapy. Rheumatology (Oxford) (2009) 0.75